MedTrace Logo

Lead Extract Study

NCT01169441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-07-26

No results posted yet for this study

Summary

The recent expansion of indications for implantable cardioverter defibrillators (ICDs) has changed the population of patients being implanted. Younger and healthier patients are now being implanted for primary prevention of sudden cardiac death. Due to the younger population, the likelihood of the lead failing during the lifetime of the patient is higher and also more likely to need extraction. To reduce the risk of the lead extraction procedure and therefore reduce the number of abandon leads, ICD lead manufacturers are designing leads to offer improved chronic extractability to reduce the morbidity and mortality during these procedures.

Conditions

  • Cardiac Surgical Procedures

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • St. Paul Heart Clinic

    lead OTHER

Principal Investigators

  • Pierce J. Vatterott, M.D. · St. Paul Heart Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2010-03-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169441 on ClinicalTrials.gov